Tonix Pharmaceuticals Says It Is Developing A Vaccine Candidate Called TNX-801 As WHO Declared MPOX A Public Health Emergency Of International Concern On Aug. 14
Tonix Pharmaceuticals Says It Is Developing A Vaccine Candidate Called TNX-801 As WHO Declared MPOX A Public Health Emergency Of International Concern On Aug. 14
tonix pharmaceuticals表示正在开发一个名为TNX-801的疫苗候选者，因为世界卫生组织于8月14日宣布MPOX为国际关注的公共卫生紧急事件。
Tonix has successfully completed non-human primate studies showing protection from challenge with lethal doses of the Clade 1 monkeypox virus that is driving the new epidemic.
Tonix成功完成了非人类灵长类动物研究，这些研究表明，使用致命剂量的Clade 1猴痘病毒可以抵御挑战，这种病毒正在推动新的流行病。
Clearly more testing is ahead for TNX-801, but the technology behind it is rooted in the science of Edward Jenner's smallpox vaccine of the late 1700s, the only vaccine to successfully eradicate a contagious viral pathogen.
显然，TNX-801 还有更多测试要进行，但其背后的技术植根于爱德华·詹纳在1700年代末的天花疫苗的科学，这是唯一成功根除传染性病毒病原体的疫苗。
资讯热榜
更新时间